Fidelity Investments’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-129,638
Closed -$296K 5785
2024
Q2
$296K Buy
129,638
+69,698
+116% +$159K ﹤0.01% 2900
2024
Q1
$259K Sell
59,940
-1,374
-2% -$5.94K ﹤0.01% 2940
2023
Q4
$187K Buy
61,314
+51,182
+505% +$156K ﹤0.01% 2975
2023
Q3
$14.6K Sell
10,132
-8,116
-44% -$11.7K ﹤0.01% 3965
2023
Q2
$45.4K Sell
18,248
-946,344
-98% -$2.36M ﹤0.01% 3477
2023
Q1
$2.59M Buy
964,592
+686,025
+246% +$1.84M ﹤0.01% 2302
2022
Q4
$1.51M Sell
278,567
-221,161
-44% -$1.2M ﹤0.01% 2445
2022
Q3
$6.24M Buy
499,728
+11,021
+2% +$138K ﹤0.01% 2096
2022
Q2
$2.41M Buy
488,707
+982
+0.2% +$4.85K ﹤0.01% 2449
2022
Q1
$3.71M Buy
487,725
+377,586
+343% +$2.87M ﹤0.01% 2438
2021
Q4
$1.13M Sell
110,139
-688,161
-86% -$7.03M ﹤0.01% 2664
2021
Q3
$10.7M Sell
798,300
-15,341
-2% -$206K ﹤0.01% 2104
2021
Q2
$17.9M Buy
813,641
+41
+0% +$900 ﹤0.01% 1888
2021
Q1
$19.6M Sell
813,600
-110,339
-12% -$2.65M ﹤0.01% 1817
2020
Q4
$16.6M Sell
923,939
-3,365,752
-78% -$60.6M ﹤0.01% 1791
2020
Q3
$49.5M Sell
4,289,691
-1,370,898
-24% -$15.8M 0.01% 1198
2020
Q2
$137M Buy
5,660,589
+14,260
+0.3% +$346K 0.02% 746
2020
Q1
$62.2M Buy
5,646,329
+9,103
+0.2% +$100K 0.01% 956
2019
Q4
$149M Buy
5,637,226
+8,838
+0.2% +$234K 0.02% 753
2019
Q3
$128M Buy
5,628,388
+8,316
+0.1% +$189K 0.02% 788
2019
Q2
$172M Buy
5,620,072
+8,837
+0.2% +$271K 0.02% 700
2019
Q1
$93.1M Buy
5,611,235
+33,481
+0.6% +$556K 0.01% 941
2018
Q4
$107M Buy
5,577,754
+361,091
+7% +$6.91M 0.01% 825
2018
Q3
$273M Buy
5,216,663
+313,931
+6% +$16.4M 0.03% 553
2018
Q2
$213M Buy
4,902,732
+57,156
+1% +$2.48M 0.02% 636
2018
Q1
$180M Buy
4,845,576
+738,932
+18% +$27.4M 0.02% 733
2017
Q4
$81.5M Buy
4,106,644
+1,584,611
+63% +$31.4M 0.01% 1087
2017
Q3
$62.8M Buy
2,522,033
+567,171
+29% +$14.1M 0.01% 1199
2017
Q2
$34.1M Buy
+1,954,862
New +$34.1M ﹤0.01% 1463